Molecular-based laboratory testing confer accuracy over microscopical testing for tick identification.

As per published literature, the tick is the primary Lyme disease vector in British Columbia (BC), while the tick species is the dominant vector on the East Coast of Canada, with no . presence seen in BC. However, a recent publication reported presence of in BC which initiated this study to determine the accuracy of the microscopic identification of ticks received in the BC Centre for Disease Control (BCCDC) Public Health Laboratory and compare morphologic methods to molecular methods. Molecular testing uses a real-time PCR assay to amplify the internal transcribed spacer 2 region as a screening method for ; while Sanger sequencing tests the cytochrome c oxidase subunit 1 gene for species confirmation. Of the 209 ticks tested, 74% were , 3.8% were , and 22% were other genus including . Phylogenetic analysis was achieved through Sanger sequencing, confirming the accuracy of the real-time PCR assay. Notably, 6 of 8 tick's hosts had clear travel history outside BC, while the 2 remaining have no confirmed travel. Both the microscopic and molecular identification methods suggest that ticks are dominant in BC and ticks identified as have host travel history outside of BC. This study further underscores the importance of tick surveillance as global human travel and sometimes along with their pets facilitate tick migration.